Literature DB >> 8172753

MR spectroscopy in clinical research.

O Henriksen1.   

Abstract

MR spectroscopy (MRS) offers unique possibilities for non-invasive evaluation of biochemistry in vivo. During recent years there has been a growing body of evidence from clinical research studies on human beings using 31P and 1H MRS. The results indicate that it is possible to evaluate phosphorous energy metabolism, loss of neurones, and lactate production in a large number of brain diseases. Furthermore, 31P and 1H MRS may be particularly clinically useful in evaluation of various disorders in skeletal muscle. In the heart 31P MRS seems at the moment the most suitable for evaluation of global affections of the myocardium. In the liver 31P MRS appears to be rather insensitive and non-specific, but absolute quantification of metabolite concentrations and using metabolic "stress models" may prove useful in the future. The clinical role of MRS in oncology is still unclear, but it may be useful for non-invasive follow-up of treatment. Taken together, the evidence obtained so far certainly shows some trends for clinical applications of MRS. Methods are now available for the clinical research necessary for establishing routine clinical MRS examinations.

Entities:  

Mesh:

Year:  1994        PMID: 8172753

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  9 in total

1.  The role of relaxation time corrections for the evaluation of long and short echo time 1H MR spectra of the hippocampus by NUMARIS and LCModel techniques.

Authors:  Filip Jírů; Monika Dezortová; Martin Burian; Milan Hájek
Journal:  MAGMA       Date:  2003-10-16       Impact factor: 2.310

Review 2.  Cardiac spectroscopy: techniques, indications and clinical results.

Authors:  Meinrad Beer
Journal:  Eur Radiol       Date:  2004-03-06       Impact factor: 5.315

Review 3.  13C imaging-a new diagnostic platform.

Authors:  Sven Månsson; Edvin Johansson; Peter Magnusson; Chun-Ming Chai; Georg Hansson; J Stefan Petersson; Freddy Ståhlberg; Klaes Golman
Journal:  Eur Radiol       Date:  2005-06-14       Impact factor: 5.315

4.  Changes in muscular lipids in unilateral isolated hypertrophy of gastrocnemius muscle can be revealed by 1H MR spectroscopy.

Authors:  Klaus Brechtel; Juergen Machann; Margarete Pick; Juergen F Schaefer; Claus D Claussen; Fritz Schick
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

5.  Dysembryoplastic neuroepithelial tumor: radiological findings (including PET, SPECT, and MRS) and surgical strategy.

Authors:  D Y Lee; C K Chung; Y S Hwang; G Choe; J G Chi; H J Kim; B K Cho
Journal:  J Neurooncol       Date:  2000-04       Impact factor: 4.130

6.  Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery.

Authors:  So-Hyang Im; Chun Kee Chung; Byung-Kyu Cho; Kyu-Chang Wang; In-Kyu Yu; In Chan Song; Gi Jeong Cheon; Dong Soo Lee; Na-Rae Kim; Je G Chi
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

7.  Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.

Authors:  Paul F Laeseke; Ru Chen; R Brooke Jeffrey; Teresa A Brentnall; Jürgen K Willmann
Journal:  Radiology       Date:  2015-12       Impact factor: 11.105

8.  Combined MRI and ³¹P-MRS investigations of the ACTA1(H40Y) mouse model of nemaline myopathy show impaired muscle function and altered energy metabolism.

Authors:  Charlotte Gineste; Yann Le Fur; Christophe Vilmen; Arnaud Le Troter; Emilie Pecchi; Patrick J Cozzone; Edna C Hardeman; David Bendahan; Julien Gondin
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Multimodal MRI and (31)P-MRS investigations of the ACTA1(Asp286Gly) mouse model of nemaline myopathy provide evidence of impaired in vivo muscle function, altered muscle structure and disturbed energy metabolism.

Authors:  Charlotte Gineste; Guillaume Duhamel; Yann Le Fur; Christophe Vilmen; Patrick J Cozzone; Kristen J Nowak; David Bendahan; Julien Gondin
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.